Abstracts Archive - Page 2416 of 2607 - ACR Meeting Abstracts

Abstract Number: 234 • 2013 ACR/ARHP Annual Meeting
The Power Doppler Modalities Of 5 Ultrasound Machines Perform Very Differently, Ascertained By a Microvessel Flow Phantom
David F. Ten Cate¹, Jolanda J. Luime², Myrthe van der Ven², Johanna M.W. Hazes², Klazina Kooiman³, Nico De Jong³ and Johannes G. Bosch³, ¹Department of Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, ²Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, ³Biomedical Engineering, Erasmus University Medical Center, Rotterdam, Netherlands
Background/Purpose: In many patients with rheumatoid arthritis (RA) subclinical disease activity can be detected with ultrasound (US), especially using power Doppler US (PDUS).[1-3] However, in…
Abstract Number: 235 • 2013 ACR/ARHP Annual Meeting
Meniscal Extrusion Is a Better Predictor Of Radiographic Osteoarthritis Change Over Ten Years Compared To Cartilage Volume Loss
Louisa Chou¹, Hussain Ijaz Khan¹, Andrew McBride¹, Dawn Aitken¹, Changhai Ding², Leigh Blizzard³, Jean-Pierre Pelletier⁴, Johanne martel-Pelletier⁴, Flavia Cicuttini⁵ and Graeme Jones², ¹Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart, 7000, Australia, ²Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, ³Statistics, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, ⁴Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, ⁵Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
· Background/Purpose: Change in joint space narrowing (JSN) on radiographs is currently the gold standard for monitoring disease progression of knee osteoarthritis in clinical trials…
Abstract Number: 236 • 2013 ACR/ARHP Annual Meeting
Hip Bone Marrow Lesions In Asymptomatic and Osteoarthritic Adults: Prevalence, Risk Factors and Significance
L Dawson¹, Yuanyuan Wang¹, Anita Wluka², Kim Bennell³, Andrew Teichtahl⁴ and Flavia Cicuttini², ¹Monash University, Melbourne, Australia, ²Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, ³University of Melbourne, Melbourne, Australia, ⁴Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
Background/Purpose: Bone marrow lesions (BMLs) at the knee have an important role in the pathogenesis of osteoarthritis (OA), being associated with increased pain, accelerated cartilage…
Abstract Number: 237 • 2013 ACR/ARHP Annual Meeting
The Association Of Radiographic Disease With Lesions On MRI In Lateral Compartment Knee Osteoarthritis: The Osteoathritis Initiative
Barton L. Wise¹, Jingbo Niu², Felix Liu³, John A. Lynch⁴, Yuqing Zhang⁵, Ali Guermazi⁶, David T. Felson⁵, C. Kent Kwoh⁷ and Nancy E. Lane¹, ¹Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA, ²Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ³University of California at San Francisco, San Francisco, CA, ⁴Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, ⁵Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁶Boston University, Boston, MA, ⁷School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Lateral compartment knee tibio-femoral radiographic osteoarthritis (ROA) is associated with pain and disability, and the epidemiology of this form of knee OA is…
Abstract Number: 238 • 2013 ACR/ARHP Annual Meeting
Structural Predictors Of Ten Year Knee Cartilage Volume Loss
Dawn Aitken¹, Hussain Ijaz Khan¹, Changhai Ding², Leigh Blizzard³, Jean-Pierre Pelletier⁴, Johanne Martel-Pelletier⁴, Flavia Cicuttini⁵ and Graeme Jones², ¹Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart, 7000, Australia, ²Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, ³Statistics, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, ⁴Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, ⁵Department of Epidemiology and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, 3004, Australia
Background/Purpose: Cartilage volume loss is considered a key feature of knee osteoarthritis (OA) and increased loss over two years is associated with future knee replacement…
Abstract Number: 239 • 2013 ACR/ARHP Annual Meeting
A Family History Of Knee Joint Replacement Increases The Progression Of Knee Joint Radiographic Osteoarthritis and Cartilage Volume Loss Over Ten Years
Hussain Ijaz Khan¹, Dawn Aitken¹, Louisa Chou¹, Andrew McBride¹, Changhai Ding², Jean Pierre Pelletier^3,4, Johanne M. Pelletier⁵, Leigh Blizzard⁶, Flavia Cicuttini⁷ and Graeme Jones², ¹Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart, 7000, Australia, ²Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, ³Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, QC, Canada, ⁴Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada, ⁵Pharmacology, Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, QC, Canada, ⁶Statistics, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, ⁷Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Background/Purpose: Osteoarthritis (OA) is a disease of multifactorial origin with a modest but significant heritable effect for disease severity in the knee joint. The aim…
Abstract Number: 200 • 2013 ACR/ARHP Annual Meeting
Hydroxychloroquine Use Among Systemic Lupus Erythematosus Patients In An Academic Rheumatology Practice
James G. Miceli¹ and Harry D. Fischer², ¹Internal Medicine, Beth Israel Medical Center, New York, NY, ²Division of Rheumatology, Albert Einstein College of Medicine at Beth Israel Medical Center, New York, NY
Background/Purpose: Hydroxychloroquine (HCQ) is a mainstay in the current treatment of systemic lupus erythematosus (SLE). HCQ has been shown to reduce the incidence of SLE…
Abstract Number: 216 • 2013 ACR/ARHP Annual Meeting
Systematic Staging For Uric Acid Deposits With Dual-Energy Computed Tomography and Ultrasound In Suspected Gout
Wolfgang A. Schmidt¹ and Alexander Huppertz², ¹Med Ctr Rheumatology Berlin Buch, Immanuel Krankenhaus Berlin, Berlin, Germany, ²Imaging Science Institute Charité, Berlin, Germany
Background/Purpose: To evaluate the diagnostic accuracy of Dual-Energy Computed Tomography (DECT) and ultrasound for detecting monosodium urate crystal deposits in patients with clinically suspected gout.…
Abstract Number: 201 • 2013 ACR/ARHP Annual Meeting
Comparison To Organisational Models For EARLY Rheumatoid Arthritis Management: Routine Care Versus EARLY Arthritis Clinic
Giovanni Ciancio¹, Ilaria Farina², Federica Pignatti³ and Marcello Govoni¹, ¹Department of Clinical and Experimental Medicine, Rheumatology Unit-Azienda Ospedaliera-Universitaria Sant'Anna, Ferrara, Italy, ²A.O.U. S.Anna di Cona, Ferrara, Italy, ³Department of Clinical and Experimental Medicine, Rheumatology Unit-Azienda Ospedaliera-Universitaria Sant'Anna, Ferrara, Italy, ferrara, Italy
Background/Purpose: although the Early Arthritis Clinic (EAC) institution is considered the best approach for the management of rheumatoid arthritis (RA) at an early stage, to…
Abstract Number: 202 • 2013 ACR/ARHP Annual Meeting
Analysis Of Non-Steroidal Anti-Inflammatory Drug Burden Among Rheumatoid Arthritis Patients Using The Dougados Algorithm
E Alemao¹, L Xie², R Wong¹, G Lltalien¹ and O Baser³, ¹Bristol-Myers Squibb, Princeton, NJ, ²SATinMED Research, Ann Arbor, MI, ³STATinMED Research and University of Michigan, Ann Arbor, MI
Background/Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are used to alleviate RA pain symptoms, but they may be associated with adverse events. Previous studies examining clinical and…
Abstract Number: 203 • 2013 ACR/ARHP Annual Meeting
Belief In Self-Adjustability Of Medication Dosing Is Negatively Correlated With Medication Adherence In Patients With Rheumatoid Arthritis
Wenxin Sun¹, Dianne Carrol Tan Bautista², Xiaohui Xin³, Yu Ting Saw³, Wee Boon Tan³, Kanchanadevi Balasubramaniam³, Wan Pin Lee⁴, Steve Thein Htay Oo³, Yin Bun Cheung² and Julian Thumboo⁵, ¹Duke-NUS Graduate Medical School, Singapore, Singapore, ²Center for Quantitative Medicine, Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore, Singapore, ³Academic Clinical Programme, Division of Medicine, Singapore General Hospital, Singapore, Singapore, ⁴Operation and Performance Management, Singapore General Hospital, Singapore, Singapore, ⁵Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore
Background/Purpose: Medication adherence in Rheumatoid Arthritis (RA) is reported to be generally low. This major problem needs to be addressed because it leads to reduced…
Abstract Number: 204 • 2013 ACR/ARHP Annual Meeting
Evaluation Of Hospitalizations and Costs In Patients With Rheumatoid Arthritis In United States Medicare Population
E Alemao¹, L Wang², G Lltalien¹, O Baser³, H Yuce⁴ and M Hochberg⁵, ¹Bristol-Myers Squibb, Princeton, NJ, ²STATinMED Research, Dallas, TX, ³STATinMED Research and University of Michigan, Ann Arbor, MI, ⁴New York City College of Technology (CUNY), Brooklyn, NJ, ⁵University of Maryland, Baltimore, MD
Background/Purpose: RA-related hospitalization and surgery (e.g. total joint arthroplasty [TJA]) are important long-term outcomes in RA. While advances in treatment for RA have resulted in…
Abstract Number: 205 • 2013 ACR/ARHP Annual Meeting
Temporal Trends In The Prescribing Of Disease Modifying Anti-Rheumatic Drugs For Rheumatoid Arthritis and The Impact Of Guidelines
Gemma L Wallace¹, C. J. Edwards², Nigel K. Arden³, Daniel Prieto-Alhambra⁴ and Andrew Judge⁵, ¹NDORMS, University of Oxford, Oxford, United Kingdom, ²Rheumatology, University Hospital Southampton, Southampton, United Kingdom, ³NDORMS; MRC Lifecourse Epidemiology Unit, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, ⁴Internal Medicine; Primary Care; NDORMS Dept; MRC Lifecourse Epidemiology Unit, URFOA-IMIM, Parc de Salut Mar; Idiap Jordi Gol; University of Oxford; University of Southampton, Barcelona, Spain, ⁵Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom
Background/Purpose: Disease modifying anti-rheumatic drugs (DMARDs) are standard initial treatments for rheumatoid arthritis (RA). Many RA treatment guidelines have been published including from the American…
Abstract Number: 206 • 2013 ACR/ARHP Annual Meeting
American College Of Rheumatology’s Rheumatology Informatics System For Effectiveness Registry Pilot
Peter J. Embi¹, William Stephens² and Rachel Myslinski³, ¹Biomedical Informatics & Internal Medicine, The Ohio State University, Columbus, OH, ²College of Medicine, Ohio State University, Columbus, OH, ³Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA
Background/Purpose: There is a significant need in the rheumatology community to access and integrate data across diverse patient populations in order to aid quality improvement…
Abstract Number: 207 • 2013 ACR/ARHP Annual Meeting
Frequency and Predictors Of Hypertension Communication In Rheumatoid Arthritis Visits
Christie M. Bartels¹, Heather Johnson², Elizabeth A. Jacobs³, Patrick McBride² and Maureen Smith⁴, ¹Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ²Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ³Department of Medicine, General Internal Medicine Division, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁴Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: Patients with rheumatoid arthritis (RA) have a 60% higher cardiovascular disease (CVD) event risk, yet previously we demonstrated they were ~30% less likely to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].